Login

Regenxbio Expands Build-to-Suit Lease in Rockville Biotech Hub

Gene Therapy Developer Set to Fully Occupy Headquarters Building
Regenxbio is scheduled to move into its new headquarters by mid-2020. (CoStar)
Regenxbio is scheduled to move into its new headquarters by mid-2020. (CoStar)
By Bryce Meyers
CoStar News
November 11, 2019 | 8:54 P.M.

Regenxbio initially agreed to lease a portion of a build-to-suit headquarters and research facility that is less than a year out from completion in Rockville, Maryland. Now, the gene therapy developer is electing to take the whole thing.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE